Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement with MGI Tech and Complete Genomics, USA, granting Swiss Rockets a perpetual, ...

CHICAGO, April 28, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing announced a collaboration with Velsera, a leading global healthcare technology company, to deliver ...

BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing technologies, will showcase its expanded portfolio for oncology and infectious disease research at ...

BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (SOPH) (NASDAQ: SOPH), a global leader in ...

The DNBSEQ-T1+ is a next-generation mid-throughput sequencer that completes a paired end 150 sequencing workflow in just 24 hours with Q40 accuracy. With three flow cell formats, two to four ...

SAN JOSE, Calif., March 25, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has entered a ...

SAN JOSE, Calif., April 15, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced four winners from 30 applicants to its Spatial Xcellerator Grant Program.

The commentary in this article is provided by Dr. Radoje Drmanac, Chief Scientific Officer of MGI and Co-Founder of Complete Genomics. Celebrating the 10 th anniversary of our proprietary DNBSEQ ™ ...